Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases.
Burke, K. E., Kochar, B., Allegretti, J. R., Winter, R. W., Lochhead, P., Khalili, H., Colizzo, F. P., Hamilton, M. J., Chan, W. W., & Ananthakrishnan, A. N. (2021). Inflammatory bowel diseases, 27(2), 155–161. https://doi.org/10.1093/ibd/izaa278
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665507/
Clinical Outcomes of Covid-19 in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.
Derikx, L., Lantinga, M. A., de Jong, D. J., et al. (2020). Journal of Crohn’s & colitis, jjaa215. Advance online publication. https://doi.org/10.1093/ecco-jcc/jjaa215
